Insider · CIK 0001746822
Albert Luderer
Files at BNGO (Bionano Genomics, Inc.). First filing Aug 21, 2026, latest Sep 9, 2026.
In brief
Albert Luderer files SEC Form 4 as CEO and director at BNGO (Bionano Genomics, Inc.). Since Aug 21, 2026, Albert Luderer has reported 2 open-market buys worth $9,705 and 0 open-market sells worth $0, the latest filed on Sep 9, 2026.
A track record needs three past buys with six months of prices behind them; Albert Luderer has 0, so none is measured yet.
The newest scored trade: bought $4,845 of BNGO on Sep 4, 2026, filed Sep 9, 2026, scored 48 (moderate). In the last 12 months: 2 buys worth $9,705 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BNGO: Bionano Genomics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | BNGObuy Bionano Genomics, Inc. | $4,845 4,000 shares | +100% | +13% from low-76% from high | |
| 41Moderate | BNGObuy Bionano Genomics, Inc. | $4,860 4,000 shares | - | +13% from low-76% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | BNGO Bionano Genomics, Inc. | POpen-market purchase Common Stockindirect: Traditional IRA | +4,000 | $1.21 | $4,845 | 8,000 | 34 d ago |
| Aug 21, 2026 | BNGO Bionano Genomics, Inc. | POpen-market purchase Common Stockindirect: Traditional IRA | +4,000 | $1.22 | $4,860 | 4,000 | Aug 21, 2026 |
| Jun 11, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,775 | $0.00 | $0 | 2,775 | Jun 12, 2025 |
Questions about Albert Luderer
Answered from the filings on this page, as of the latest one.
Is Albert Luderer buying or selling?
In the last 12 months Albert Luderer reported 2 open-market buys worth $9,705 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $4,845 of BNGO on Sep 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Albert Luderer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Albert Luderer has 0.
Where does Albert Luderer file Form 4?
Albert Luderer has filed Form 4 at BNGO (Bionano Genomics, Inc.) as Interim Chief Executive. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.